Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

VEGF165b Protein, Human, Recombinant

(Synonyms: VPF, VEGF-A, VEGF, MVCD1, L-VEGF) Copy Product Info

Synonyms: VPF, VEGF-A, VEGF, MVCD1, L-VEGF

Catalog No. TMPY-04983 Copy Product Info
VEGF165B Protein, Human, Recombinant is expressed in Baculovirus-Insect Cells. The accession number is P15692-8.
VEGF165b Protein, Human, Recombinant
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
5 µg$987-10 days7-10 days
10 µg$1677-10 days7-10 days
20 µg$2757-10 days7-10 days
50 µg$4297-10 days7-10 days
100 µg$7157-10 days7-10 days
200 µg$9877-10 days7-10 days
500 µg$1,9807-10 days7-10 days
1 mg$3,9707-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Bioactivity
Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Description
VEGF165B Protein, Human, Recombinant is expressed in Baculovirus-Insect Cells. The accession number is P15692-8.
Species
Human
Expression System
Baculovirus Insect Cells
TagTag Free
Accession NumberP15692-8
ConstructionA DNA sequence encoding the human VEGFA (NP_001165100.1) (Met1-Asp191) was expressed.
Protein Purity
> 95% as determined by SDS-PAGE.
Endotoxin< 1.0 EU/μg of the protein as determined by the LAL method.
FormulationLyophilized from sterile 100 mM Glycine, 10 mM Nacl pH 6.0. Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
ReconstitutionPlease refer to the lot-specific COA.
SynonymsVPF, VEGF-A, VEGF, MVCD1, L-VEGF
Research Background
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Chemical Properties
Molecular Weight19.1 kDa (predicted)
Relative Density.no data available
Storage & Solubility Information
ShippingIn general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
StorageIt is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.

Calculator

  • Reconstitution Calculator
  • Recombinant Protein Dilution Calculator
  • Specific Activity Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Related Tags: VEGF165b Protein, Human, Recombinant chemical structure | VEGF165b Protein, Human, Recombinant molecular weight